Loading…

Diminished expression of CD40 ligand may contribute to the defective humoral immunity in patients with MHC class II deficiency

Major histocompatibility complex (MHC) class II deficiency (bare lymphocyte syndrome, BLS) is a rare primary immunodeficiency classified as a subgroup of severe combined immunodeficiency. We studied T and B lymphocyte function by examining the CD40 ligand/CD40 system in three BLS patients from two u...

Full description

Saved in:
Bibliographic Details
Published in:European journal of immunology 1998-02, Vol.28 (2), p.589-598
Main Authors: Nonoyama, Shigeaki, Etzioni, Amos, Toru, Hano, Ruggerie, Dennis P., Lewis, David, Pollack, Shimon, Aruffo, Alejandro, Yata, Jun‐Ichi, Ochs, Hans D.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c4829-2b8e79ca7b008a16b7206b3a285e1e54892179813032e7148942abb549edd97b3
container_end_page 598
container_issue 2
container_start_page 589
container_title European journal of immunology
container_volume 28
creator Nonoyama, Shigeaki
Etzioni, Amos
Toru, Hano
Ruggerie, Dennis P.
Lewis, David
Pollack, Shimon
Aruffo, Alejandro
Yata, Jun‐Ichi
Ochs, Hans D.
description Major histocompatibility complex (MHC) class II deficiency (bare lymphocyte syndrome, BLS) is a rare primary immunodeficiency classified as a subgroup of severe combined immunodeficiency. We studied T and B lymphocyte function by examining the CD40 ligand/CD40 system in three BLS patients from two unrelated families. CD40 ligand expression by maximally activated BLS T cells was diminished. This abnormality may represent immunological naïveté rather than a general T cell defect, since expression of activation marker CD69 and proliferative responses to PHA or anti‐CD3 were normal, and BLS T cells primed and restimulated in vitro expressed normal amounts of CD40 ligand. BLS B cells proliferated and produced IgE if stimulated with anti‐CD40 or soluble CD40 ligand and IL‐4. Activation of BLS B cells with soluble CD40 ligand and IL‐4 induced normal expression of activation markers, although MHC class II expression remained absent. Depressed antibody titers, lack of amplification and failure to undergo isotype switching in response to immunization with bacteriophage ϕ × 174 demonstrated defective T cell help. We conclude that BLS B cells are functionally normal if appropriately stimulated, and that the defective humoral immunity observed may be related to diminished expression of CD40 ligand on BLS T cells.
doi_str_mv 10.1002/(SICI)1521-4141(199802)28:02<589::AID-IMMU589>3.0.CO;2-J
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79754002</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>16410256</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4829-2b8e79ca7b008a16b7206b3a285e1e54892179813032e7148942abb549edd97b3</originalsourceid><addsrcrecordid>eNqFkU9v1DAQxS0EKkvhIyD5hNpDlrHjJPZSIaos0FRd7QEqIXGwnGSWNcqfJXYoufDZ8WqXXkDqxdbMvPfG8o-QdwzmDIC_PvtU5MU5SziLBBPsjCklgZ9zuQB-kUi1WFwWy6hYrW5D8Taewzxfv-HR9SMyuzc9JjMAJiIerE_JM-e-A4BKE3VCTlQQQapm5PfStrazbos1xV-7AZ2zfUf7Dc2XAmhjv5mupq2ZaNV3frDl6JH6nvot0ho3WHn7E-l2bPvBNNS27dhZP1Hb0Z3xFjvv6J31W7q6ymnVGOdoUeyNtgrDanpOnmxM4_DF8T4ltx_ef86vopv1xyK_vIkqIbmKeCkxU5XJSgBpWFpmHNIyNlwmyDARUnGWKcliiDlmLNSCm7JMhMK6VlkZn5JXh9zd0P8Y0XndWldh05gO-9HpTGWJCB__oJClggFP0iD8chBWQ-_cgBu9G2xrhkkz0HuGWu8Z6j0OvcehDww1lzqcAZvWgaE-MtSxBp2vNdfXIfrl8Q1j2WJ9H3yEFuZfD_M72-D0z96H1v5_699W_Ad3-rho</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16410256</pqid></control><display><type>article</type><title>Diminished expression of CD40 ligand may contribute to the defective humoral immunity in patients with MHC class II deficiency</title><source>Wiley:Jisc Collections:Wiley Read and Publish Open Access 2024-2025 (reading list)</source><creator>Nonoyama, Shigeaki ; Etzioni, Amos ; Toru, Hano ; Ruggerie, Dennis P. ; Lewis, David ; Pollack, Shimon ; Aruffo, Alejandro ; Yata, Jun‐Ichi ; Ochs, Hans D.</creator><creatorcontrib>Nonoyama, Shigeaki ; Etzioni, Amos ; Toru, Hano ; Ruggerie, Dennis P. ; Lewis, David ; Pollack, Shimon ; Aruffo, Alejandro ; Yata, Jun‐Ichi ; Ochs, Hans D.</creatorcontrib><description>Major histocompatibility complex (MHC) class II deficiency (bare lymphocyte syndrome, BLS) is a rare primary immunodeficiency classified as a subgroup of severe combined immunodeficiency. We studied T and B lymphocyte function by examining the CD40 ligand/CD40 system in three BLS patients from two unrelated families. CD40 ligand expression by maximally activated BLS T cells was diminished. This abnormality may represent immunological naïveté rather than a general T cell defect, since expression of activation marker CD69 and proliferative responses to PHA or anti‐CD3 were normal, and BLS T cells primed and restimulated in vitro expressed normal amounts of CD40 ligand. BLS B cells proliferated and produced IgE if stimulated with anti‐CD40 or soluble CD40 ligand and IL‐4. Activation of BLS B cells with soluble CD40 ligand and IL‐4 induced normal expression of activation markers, although MHC class II expression remained absent. Depressed antibody titers, lack of amplification and failure to undergo isotype switching in response to immunization with bacteriophage ϕ × 174 demonstrated defective T cell help. We conclude that BLS B cells are functionally normal if appropriately stimulated, and that the defective humoral immunity observed may be related to diminished expression of CD40 ligand on BLS T cells.</description><identifier>ISSN: 0014-2980</identifier><identifier>EISSN: 1521-4141</identifier><identifier>DOI: 10.1002/(SICI)1521-4141(199802)28:02&lt;589::AID-IMMU589&gt;3.0.CO;2-J</identifier><identifier>PMID: 9521069</identifier><language>eng</language><publisher>Weinheim: WILEY‐VCH Verlag GmbH</publisher><subject>Antibodies, Viral - biosynthesis ; B cell ; Bacteriophage phi X 174 - immunology ; CD40 Antigens - physiology ; CD40 Ligand ; Female ; Helper function ; Histocompatibility Antigens Class II - biosynthesis ; Histocompatibility Antigens Class II - blood ; Humans ; Immunodeficiency ; Immunoglobulins - biosynthesis ; Immunoglobulins - blood ; Immunoglobulins - deficiency ; Infant ; Ligands ; Lymphocyte Activation ; Male ; Membrane Glycoproteins - biosynthesis ; MHC class II ; Severe Combined Immunodeficiency - blood ; Severe Combined Immunodeficiency - immunology ; T cell</subject><ispartof>European journal of immunology, 1998-02, Vol.28 (2), p.589-598</ispartof><rights>1998 WILEY‐VCH Verlag GmbH, Weinheim, Fed. Rep. of Germany</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c4829-2b8e79ca7b008a16b7206b3a285e1e54892179813032e7148942abb549edd97b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9521069$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nonoyama, Shigeaki</creatorcontrib><creatorcontrib>Etzioni, Amos</creatorcontrib><creatorcontrib>Toru, Hano</creatorcontrib><creatorcontrib>Ruggerie, Dennis P.</creatorcontrib><creatorcontrib>Lewis, David</creatorcontrib><creatorcontrib>Pollack, Shimon</creatorcontrib><creatorcontrib>Aruffo, Alejandro</creatorcontrib><creatorcontrib>Yata, Jun‐Ichi</creatorcontrib><creatorcontrib>Ochs, Hans D.</creatorcontrib><title>Diminished expression of CD40 ligand may contribute to the defective humoral immunity in patients with MHC class II deficiency</title><title>European journal of immunology</title><addtitle>Eur J Immunol</addtitle><description>Major histocompatibility complex (MHC) class II deficiency (bare lymphocyte syndrome, BLS) is a rare primary immunodeficiency classified as a subgroup of severe combined immunodeficiency. We studied T and B lymphocyte function by examining the CD40 ligand/CD40 system in three BLS patients from two unrelated families. CD40 ligand expression by maximally activated BLS T cells was diminished. This abnormality may represent immunological naïveté rather than a general T cell defect, since expression of activation marker CD69 and proliferative responses to PHA or anti‐CD3 were normal, and BLS T cells primed and restimulated in vitro expressed normal amounts of CD40 ligand. BLS B cells proliferated and produced IgE if stimulated with anti‐CD40 or soluble CD40 ligand and IL‐4. Activation of BLS B cells with soluble CD40 ligand and IL‐4 induced normal expression of activation markers, although MHC class II expression remained absent. Depressed antibody titers, lack of amplification and failure to undergo isotype switching in response to immunization with bacteriophage ϕ × 174 demonstrated defective T cell help. We conclude that BLS B cells are functionally normal if appropriately stimulated, and that the defective humoral immunity observed may be related to diminished expression of CD40 ligand on BLS T cells.</description><subject>Antibodies, Viral - biosynthesis</subject><subject>B cell</subject><subject>Bacteriophage phi X 174 - immunology</subject><subject>CD40 Antigens - physiology</subject><subject>CD40 Ligand</subject><subject>Female</subject><subject>Helper function</subject><subject>Histocompatibility Antigens Class II - biosynthesis</subject><subject>Histocompatibility Antigens Class II - blood</subject><subject>Humans</subject><subject>Immunodeficiency</subject><subject>Immunoglobulins - biosynthesis</subject><subject>Immunoglobulins - blood</subject><subject>Immunoglobulins - deficiency</subject><subject>Infant</subject><subject>Ligands</subject><subject>Lymphocyte Activation</subject><subject>Male</subject><subject>Membrane Glycoproteins - biosynthesis</subject><subject>MHC class II</subject><subject>Severe Combined Immunodeficiency - blood</subject><subject>Severe Combined Immunodeficiency - immunology</subject><subject>T cell</subject><issn>0014-2980</issn><issn>1521-4141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><recordid>eNqFkU9v1DAQxS0EKkvhIyD5hNpDlrHjJPZSIaos0FRd7QEqIXGwnGSWNcqfJXYoufDZ8WqXXkDqxdbMvPfG8o-QdwzmDIC_PvtU5MU5SziLBBPsjCklgZ9zuQB-kUi1WFwWy6hYrW5D8Taewzxfv-HR9SMyuzc9JjMAJiIerE_JM-e-A4BKE3VCTlQQQapm5PfStrazbos1xV-7AZ2zfUf7Dc2XAmhjv5mupq2ZaNV3frDl6JH6nvot0ho3WHn7E-l2bPvBNNS27dhZP1Hb0Z3xFjvv6J31W7q6ymnVGOdoUeyNtgrDanpOnmxM4_DF8T4ltx_ef86vopv1xyK_vIkqIbmKeCkxU5XJSgBpWFpmHNIyNlwmyDARUnGWKcliiDlmLNSCm7JMhMK6VlkZn5JXh9zd0P8Y0XndWldh05gO-9HpTGWJCB__oJClggFP0iD8chBWQ-_cgBu9G2xrhkkz0HuGWu8Z6j0OvcehDww1lzqcAZvWgaE-MtSxBp2vNdfXIfrl8Q1j2WJ9H3yEFuZfD_M72-D0z96H1v5_699W_Ad3-rho</recordid><startdate>199802</startdate><enddate>199802</enddate><creator>Nonoyama, Shigeaki</creator><creator>Etzioni, Amos</creator><creator>Toru, Hano</creator><creator>Ruggerie, Dennis P.</creator><creator>Lewis, David</creator><creator>Pollack, Shimon</creator><creator>Aruffo, Alejandro</creator><creator>Yata, Jun‐Ichi</creator><creator>Ochs, Hans D.</creator><general>WILEY‐VCH Verlag GmbH</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>199802</creationdate><title>Diminished expression of CD40 ligand may contribute to the defective humoral immunity in patients with MHC class II deficiency</title><author>Nonoyama, Shigeaki ; Etzioni, Amos ; Toru, Hano ; Ruggerie, Dennis P. ; Lewis, David ; Pollack, Shimon ; Aruffo, Alejandro ; Yata, Jun‐Ichi ; Ochs, Hans D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4829-2b8e79ca7b008a16b7206b3a285e1e54892179813032e7148942abb549edd97b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Antibodies, Viral - biosynthesis</topic><topic>B cell</topic><topic>Bacteriophage phi X 174 - immunology</topic><topic>CD40 Antigens - physiology</topic><topic>CD40 Ligand</topic><topic>Female</topic><topic>Helper function</topic><topic>Histocompatibility Antigens Class II - biosynthesis</topic><topic>Histocompatibility Antigens Class II - blood</topic><topic>Humans</topic><topic>Immunodeficiency</topic><topic>Immunoglobulins - biosynthesis</topic><topic>Immunoglobulins - blood</topic><topic>Immunoglobulins - deficiency</topic><topic>Infant</topic><topic>Ligands</topic><topic>Lymphocyte Activation</topic><topic>Male</topic><topic>Membrane Glycoproteins - biosynthesis</topic><topic>MHC class II</topic><topic>Severe Combined Immunodeficiency - blood</topic><topic>Severe Combined Immunodeficiency - immunology</topic><topic>T cell</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nonoyama, Shigeaki</creatorcontrib><creatorcontrib>Etzioni, Amos</creatorcontrib><creatorcontrib>Toru, Hano</creatorcontrib><creatorcontrib>Ruggerie, Dennis P.</creatorcontrib><creatorcontrib>Lewis, David</creatorcontrib><creatorcontrib>Pollack, Shimon</creatorcontrib><creatorcontrib>Aruffo, Alejandro</creatorcontrib><creatorcontrib>Yata, Jun‐Ichi</creatorcontrib><creatorcontrib>Ochs, Hans D.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nonoyama, Shigeaki</au><au>Etzioni, Amos</au><au>Toru, Hano</au><au>Ruggerie, Dennis P.</au><au>Lewis, David</au><au>Pollack, Shimon</au><au>Aruffo, Alejandro</au><au>Yata, Jun‐Ichi</au><au>Ochs, Hans D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Diminished expression of CD40 ligand may contribute to the defective humoral immunity in patients with MHC class II deficiency</atitle><jtitle>European journal of immunology</jtitle><addtitle>Eur J Immunol</addtitle><date>1998-02</date><risdate>1998</risdate><volume>28</volume><issue>2</issue><spage>589</spage><epage>598</epage><pages>589-598</pages><issn>0014-2980</issn><eissn>1521-4141</eissn><abstract>Major histocompatibility complex (MHC) class II deficiency (bare lymphocyte syndrome, BLS) is a rare primary immunodeficiency classified as a subgroup of severe combined immunodeficiency. We studied T and B lymphocyte function by examining the CD40 ligand/CD40 system in three BLS patients from two unrelated families. CD40 ligand expression by maximally activated BLS T cells was diminished. This abnormality may represent immunological naïveté rather than a general T cell defect, since expression of activation marker CD69 and proliferative responses to PHA or anti‐CD3 were normal, and BLS T cells primed and restimulated in vitro expressed normal amounts of CD40 ligand. BLS B cells proliferated and produced IgE if stimulated with anti‐CD40 or soluble CD40 ligand and IL‐4. Activation of BLS B cells with soluble CD40 ligand and IL‐4 induced normal expression of activation markers, although MHC class II expression remained absent. Depressed antibody titers, lack of amplification and failure to undergo isotype switching in response to immunization with bacteriophage ϕ × 174 demonstrated defective T cell help. We conclude that BLS B cells are functionally normal if appropriately stimulated, and that the defective humoral immunity observed may be related to diminished expression of CD40 ligand on BLS T cells.</abstract><cop>Weinheim</cop><pub>WILEY‐VCH Verlag GmbH</pub><pmid>9521069</pmid><doi>10.1002/(SICI)1521-4141(199802)28:02&lt;589::AID-IMMU589&gt;3.0.CO;2-J</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0014-2980
ispartof European journal of immunology, 1998-02, Vol.28 (2), p.589-598
issn 0014-2980
1521-4141
language eng
recordid cdi_proquest_miscellaneous_79754002
source Wiley:Jisc Collections:Wiley Read and Publish Open Access 2024-2025 (reading list)
subjects Antibodies, Viral - biosynthesis
B cell
Bacteriophage phi X 174 - immunology
CD40 Antigens - physiology
CD40 Ligand
Female
Helper function
Histocompatibility Antigens Class II - biosynthesis
Histocompatibility Antigens Class II - blood
Humans
Immunodeficiency
Immunoglobulins - biosynthesis
Immunoglobulins - blood
Immunoglobulins - deficiency
Infant
Ligands
Lymphocyte Activation
Male
Membrane Glycoproteins - biosynthesis
MHC class II
Severe Combined Immunodeficiency - blood
Severe Combined Immunodeficiency - immunology
T cell
title Diminished expression of CD40 ligand may contribute to the defective humoral immunity in patients with MHC class II deficiency
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T06%3A24%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Diminished%20expression%20of%20CD40%20ligand%20may%20contribute%20to%20the%20defective%20humoral%20immunity%20in%20patients%20with%20MHC%20class%20II%20deficiency&rft.jtitle=European%20journal%20of%20immunology&rft.au=Nonoyama,%20Shigeaki&rft.date=1998-02&rft.volume=28&rft.issue=2&rft.spage=589&rft.epage=598&rft.pages=589-598&rft.issn=0014-2980&rft.eissn=1521-4141&rft_id=info:doi/10.1002/(SICI)1521-4141(199802)28:02%3C589::AID-IMMU589%3E3.0.CO;2-J&rft_dat=%3Cproquest_cross%3E16410256%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4829-2b8e79ca7b008a16b7206b3a285e1e54892179813032e7148942abb549edd97b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=16410256&rft_id=info:pmid/9521069&rfr_iscdi=true